You just read:

eFFECTOR Therapeutics to Collaborate with Pfizer and Merck KGaA, Darmstadt, Germany to Evaluate a Novel Immuno-oncology Combination in Microsatellite Stable Colorectal Cancer

News provided by

eFFECTOR Therapeutics

Jun 20, 2017, 08:00 ET